Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

INTS Intensity Therapeutics

Watchlist
0.0000.0000.00%
Close  01/27 09:30 ET
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
0.000
Volume
0.00
Market Cap
0
P/E(TTM)
0.00
52wk High
0.000
Shares
17.99M
P/E(Static)
0.00
52wk Low
0.000
Float Cap
0
Bid/Ask %
0.00%
Historical High
0.000
Shs Float
2.22M
Volume Ratio
0.00
Historical Low
0.000
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
--
Lot Size
1
Float Cap
0
Bid/Ask %
0.00%
Historical High
0.000
Shs Float
2.22M
Volume Ratio
0.00
Historical Low
0.000
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
--
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Intensity Therapeutics, Inc. engages in the operation a biotechnology company which develops novel immune-based therapeutic products for cancer treatment. Its product INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Westport, CT.
CEO: Mr. Lewis H. Bender
Market: NASDAQ
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist